Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217145 · ClinicalTrials.gov registry record · NA
PREVENT HPV -Related Cancers Trial
A NA study of HPV Vaccination and Uptake Vaccination, sponsored by University of Utah.
- Active
- Registry status
- NA
- Development phase
- 1,455
- Enrollment target
- 1
- Study location
NCT07217145: Active NA study of HPV Vaccination and Uptake Vaccination, sponsored by University of Utah.
NCT07217145 is a NA study of HPV Vaccination and Uptake Vaccination that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 1,455 participants, above the 323-participant average among 4 other HPV Vaccination trials with a reported enrollment target (350% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217145, a NA study of HPV Vaccination and Uptake Vaccination, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,455 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States. The proposed study will assess the effectiveness of clinic-based outreach to increase vaccination rates for HPV at four community clinics in rural counties in Washington. The proposed study includes the following a randomized controlled trial (RCT) that will assign adult parent/caregiver participants to a timeline for receiving intervention. This study will develop best practices, implementation guides, and dissemination of findings for other clinics to implement the program on a broader scale.
Primary Outcome
The investigators will track intervention reach using the Proctor Implementation and RE-AIM frameworks. The primary outcome is whether patients initiate the next step in the HPV vaccination series at 6 months, which will be captured via the EHR and the state vaccine registry. Completing the next step in the vaccine series outcome will be compared via logistic generalized estimating equations (GEE) models, with bias-reduced robust sandwich variance estimators clustered by the clinic. These logist
Conditions Studied
Interventions
- BIOLOGICAL PREVENT
Study Locations (1)
Washington
- Sea Mar Community Health Centers - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,455 participants |
| Start Date | 2025-10-09 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT07217145 still lists
NCT07217145 is an interventional study that assigns participants to a tested intervention. Its 1,455 participants enrollment target places it among the larger protocols in the corpus, above the 323-participant average among 4 other HPV Vaccination trials with a reported enrollment target (350% higher).
The record links to 3 conditions, with HPV Vaccination appearing as the primary indexed condition, and to 1 intervention - of which PREVENT is the first listed.
NCT07217145 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07217145 about?
NCT07217145 is a clinical study titled "PREVENT HPV -Related Cancers Trial". This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparitie...
What is the current status of trial NCT07217145?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,455 participants. The study started on 2025-10-09. Estimated completion is 2026-07-01.
What conditions does trial NCT07217145 study?
This clinical trial studies the following conditions: HPV Vaccination, Uptake Vaccination, Series Completion.
What interventions are being tested in trial NCT07217145?
The interventions under investigation include: PREVENT (BIOLOGICAL).
Who is sponsoring clinical trial NCT07217145?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217145 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
RECRUITING · NA
-
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Implementation and Effectiveness of IPP-HPV
COMPLETED · NA
-
Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI